We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Prostate Cancer Drugs Undergoing FDA Safety Review
Generic Prostate Cancer Drugs Undergoing FDA Safety Review
May 11, 2010
The FDA is conducting a safety review of a class of commonly used prostate cancer drugs, including generics, in light of a safety signal showing they may pose a small increased risk for diabetes and cardiovascular (CV) disease in men treated with the medications.